Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 13 of 100 as at 4 Nov 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores Amanat Acquisition Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (74): Smaller than most of the companies we track.
Accruals (8): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on AMAN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AMAN appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 78% of US stocks
Higher than 32% of US stocks
Higher than 30% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Amanat Acquisition Corp. has a market value of $97.8M and an enterprise value of $96.2M.
Forward dividend yield: 0.00%.
Amanat Acquisition Corp. employs 0 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| AMANAmanat Acquisition Corp. | $97.8M | 13 |
| AACAres Acquisition Corp. III | $98.0M | 6 |
| FLSCFrazier Life Sciences Acquisition Corp. II | $98.7M | 5 |
| KEYYKeystone Acquisition Corp. /New York/ | $95.2M | 15 |
| TAVITavia Acquisition Corp. | $95.0M | 67 |
| OSPROsprey Acquisition Corp. III | $101.0M | 5 |
| RACDResearch Alliance Corp. IV | $94.6M | 6 |
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Amanat Acquisition Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Corxel Pharmaceuticals and Amanat Acquisition Corp announced they have entered into a definitive business combination agreement to create a publicly listed obesity-focused biopharmaceutical company.
Why it matters — The agreement outlines a proposed business combination involving AMAN and Corxel US.
As at 4 Nov 2026, Amanat Acquisition Corp. ranks 13 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (74 of 100).
No analyst covering Amanat Acquisition Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMAN are extrapolating price history, which says nothing about the business.
Amanat Acquisition Corp Class A Ordinary Shares represents the public shares of Amanat Acquisition Corp, a special purpose acquisition company focused on identifying and completing a business combination. The company’s Class A ordinary shares are used as the publicly traded equity portion of the SPAC structure, giving investors exposure to a cash-backed vehicle formed to pursue a merger, share exchange, asset acquisition, share purchase, reorganization, or similar transaction.
The most recent item we track (GlobeNewsWire, 26 Oct 2026): "Corxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company". Corxel Pharmaceuticals and Amanat Acquisition Corp announced they have entered into a definitive business combination agreement to create a publicly listed obesity-focused biopharmaceutical company.
Amanat Acquisition Corp Class A Ordinary Shares represents the public shares of Amanat Acquisition Corp, a special purpose acquisition company focused on identifying and completing a business combination. The company’s Class A ordinary shares are used as the publicly traded equity portion of the SPAC structure, giving investors exposure to a cash-backed vehicle formed to pursue a merger, share exchange, asset acquisition, share purchase, reorganization, or similar transaction. Amanat Acquisition Corp is headquartered in Westfield, New Jersey, and concentrates on opportunities in the healthcare and healthcare-related industries. Its shares are structured as redeemable public shares, reflecting the capital-preservation features commonly associated with SPAC listings. As a blank check company, Amanat Acquisition Corp serves as a financing and acquisition platform in the capital markets, connecting public-market capital with private operating businesses seeking access to public ownership.
CEO Dr. Pavan Cheruvu M.D. · United States · https://amanatacquisition.com
